Correction: Intensive Care Med https://doi.org/10.1007/s00134-024-07375-x
When this article was published the Fig. 1 was presented in a redrawn version and the footnote was inadvertently deleted during the process.
Anzeige
Two notes to Fig. 1 should have been given:
*16/49 patients (32.6%) were already on antimicrobial therapy at the time of BAL acquisition
** therapeutic choices based on BALCX considered decisions guided by BALFAPPP as baseline
The original article has been updated. The Editorial Office apologizes for the mistake.
Anzeige
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.